Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 146 entries
Sorted by: Best Match Show Resources per page
Enhanced Surface Activity of MWW Zeolite Nanosheets Prepared via a One-Step Synthesis.

Journal of the American Chemical Society

Zhou Y, Mu Y, Hsieh MF, Kabius B, Pacheco C, Bator C, Rioux RM, Rimer JD.
PMID: 32281385
J Am Chem Soc. 2020 May 06;142(18):8211-8222. doi: 10.1021/jacs.9b13596. Epub 2020 Apr 27.

The synthesis of two-dimensional (2D) zeolites has garnered attention due to their superior properties for applications that span catalysis to selective separations. Prior studies of 2D zeolite catalysts demonstrated enhanced mass transport for improved catalyst lifetime and selectivity. Moreover,...

Cite
Zhou Y, Mu Y, Hsieh MF, et al. Enhanced Surface Activity of MWW Zeolite Nanosheets Prepared via a One-Step Synthesis. J Am Chem Soc. 2020;142(18):8211-8222doi: 10.1021/jacs.9b13596.
Zhou, Y., Mu, Y., Hsieh, M. F., Kabius, B., Pacheco, C., Bator, C., Rioux, R. M., & Rimer, J. D. (2020). Enhanced Surface Activity of MWW Zeolite Nanosheets Prepared via a One-Step Synthesis. Journal of the American Chemical Society, 142(18), 8211-8222. https://doi.org/10.1021/jacs.9b13596
Zhou, Yunwen, et al. "Enhanced Surface Activity of MWW Zeolite Nanosheets Prepared via a One-Step Synthesis." Journal of the American Chemical Society vol. 142,18 (2020): 8211-8222. doi: https://doi.org/10.1021/jacs.9b13596
Zhou Y, Mu Y, Hsieh MF, Kabius B, Pacheco C, Bator C, Rioux RM, Rimer JD. Enhanced Surface Activity of MWW Zeolite Nanosheets Prepared via a One-Step Synthesis. J Am Chem Soc. 2020 May 06;142(18):8211-8222. doi: 10.1021/jacs.9b13596. Epub 2020 Apr 27. PMID: 32281385.
Copy Download .nbib Format: NLM
A genetic association study of heart failure: more evidence for the role of BAG3 in idiopathic dilated cardiomyopathy.

ESC heart failure

de Denus S, Mottet F, Korol S, Feroz Zada Y, Provost S, Mongrain I, Asselin G, Oussaïd E, Busseuil D, Lettre G, Rioux J, Racine N, O'Meara E, White M, Rouleau J, Tardif JC, Dubé MP.
PMID: 32869539
ESC Heart Fail. 2020 Sep 01; doi: 10.1002/ehf2.12934. Epub 2020 Sep 01.

AIMS: Few investigations have been conducted to identify genetic determinants of common, polygenetic forms of heart failure (HF), and only a limited number of these genetic associations have been validated by multiple groups.METHODS AND RESULTS: We performed a case-control...

Cite
de Denus S, Mottet F, Korol S, et al. A genetic association study of heart failure: more evidence for the role of BAG3 in idiopathic dilated cardiomyopathy. ESC Heart Fail. 2020;doi: 10.1002/ehf2.12934.
de Denus, S., Mottet, F., Korol, S., Feroz Zada, Y., Provost, S., Mongrain, I., Asselin, G., Oussaïd, E., Busseuil, D., Lettre, G., Rioux, J., Racine, N., O'Meara, E., White, M., Rouleau, J., Tardif, J. C., & Dubé, M. P. (2020). A genetic association study of heart failure: more evidence for the role of BAG3 in idiopathic dilated cardiomyopathy. ESC heart failure, . https://doi.org/10.1002/ehf2.12934
de Denus, Simon, et al. "A genetic association study of heart failure: more evidence for the role of BAG3 in idiopathic dilated cardiomyopathy." ESC heart failure vol. (2020). doi: https://doi.org/10.1002/ehf2.12934
de Denus S, Mottet F, Korol S, Feroz Zada Y, Provost S, Mongrain I, Asselin G, Oussaïd E, Busseuil D, Lettre G, Rioux J, Racine N, O'Meara E, White M, Rouleau J, Tardif JC, Dubé MP. A genetic association study of heart failure: more evidence for the role of BAG3 in idiopathic dilated cardiomyopathy. ESC Heart Fail. 2020 Sep 01; doi: 10.1002/ehf2.12934. Epub 2020 Sep 01. PMID: 32869539; PMCID: PMC7754954.
Copy Download .nbib Format: NLM
Kinetics of H.

Angewandte Chemie (International ed. in English)

Mahdavi-Shakib A, Kumar KBS, Whittaker TN, Xie T, Grabow LC, Rioux RM, Chandler BD.
PMID: 33403732
Angew Chem Int Ed Engl. 2021 Mar 29;60(14):7735-7743. doi: 10.1002/anie.202013359. Epub 2021 Feb 26.

H

Cite
Mahdavi-Shakib A, Kumar KBS, Whittaker TN, et al. Kinetics of H. Angew Chem Int Ed Engl. 2021;60(14):7735-7743doi: 10.1002/anie.202013359.
Mahdavi-Shakib, A., Kumar, K. B. S., Whittaker, T. N., Xie, T., Grabow, L. C., Rioux, R. M., & Chandler, B. D. (2021). Kinetics of H. Angewandte Chemie (International ed. in English), 60(14), 7735-7743. https://doi.org/10.1002/anie.202013359
Mahdavi-Shakib, Akbar, et al. "Kinetics of H." Angewandte Chemie (International ed. in English) vol. 60,14 (2021): 7735-7743. doi: https://doi.org/10.1002/anie.202013359
Mahdavi-Shakib A, Kumar KBS, Whittaker TN, Xie T, Grabow LC, Rioux RM, Chandler BD. Kinetics of H. Angew Chem Int Ed Engl. 2021 Mar 29;60(14):7735-7743. doi: 10.1002/anie.202013359. Epub 2021 Feb 26. PMID: 33403732.
Copy Download .nbib Format: NLM
A role for CXCR3 ligands as biomarkers of post-operative Crohn's disease recurrence.

Journal of Crohn's & colitis

Walshe M, Nayeri S, Ji J, Hernandez-Rocha C, Sabic K, Hu L, Giri M, Nayar S, Brant S, McGovern DPB, Rioux JD, Duerr RH, Cho JH, Schumm PL, Lazarev M, Silverberg MS.
PMID: 34698823
J Crohns Colitis. 2021 Oct 26; doi: 10.1093/ecco-jcc/jjab186. Epub 2021 Oct 26.

BACKGROUND AND AIMS: Crohn's disease (CD) recurrence following ileocolic resection (ICR) is common. We sought to identify blood-based biomarkers associated with CD recurrence.METHODS: CD patients undergoing ICR were recruited across six centres. Serum samples were obtained at post-operative colonoscopy....

Cite
Walshe M, Nayeri S, Ji J, et al. A role for CXCR3 ligands as biomarkers of post-operative Crohn's disease recurrence. J Crohns Colitis. 2021;doi: 10.1093/ecco-jcc/jjab186.
Walshe, M., Nayeri, S., Ji, J., Hernandez-Rocha, C., Sabic, K., Hu, L., Giri, M., Nayar, S., Brant, S., McGovern, D. P. B., Rioux, J. D., Duerr, R. H., Cho, J. H., Schumm, P. L., Lazarev, M., & Silverberg, M. S. (2021). A role for CXCR3 ligands as biomarkers of post-operative Crohn's disease recurrence. Journal of Crohn's & colitis, . https://doi.org/10.1093/ecco-jcc/jjab186
Walshe, Margaret, et al. "A role for CXCR3 ligands as biomarkers of post-operative Crohn's disease recurrence." Journal of Crohn's & colitis vol. (2021). doi: https://doi.org/10.1093/ecco-jcc/jjab186
Walshe M, Nayeri S, Ji J, Hernandez-Rocha C, Sabic K, Hu L, Giri M, Nayar S, Brant S, McGovern DPB, Rioux JD, Duerr RH, Cho JH, Schumm PL, Lazarev M, Silverberg MS. A role for CXCR3 ligands as biomarkers of post-operative Crohn's disease recurrence. J Crohns Colitis. 2021 Oct 26; doi: 10.1093/ecco-jcc/jjab186. Epub 2021 Oct 26. PMID: 34698823.
Copy Download .nbib Format: NLM
Factors controlling the molecular modification of one-dimensional zeolites.

Physical chemistry chemical physics : PCCP

Li R, Elliott WA, Clark RJ, Sutjianto JG, Rioux RM, Palmer JC, Rimer JD.
PMID: 34612398
Phys Chem Chem Phys. 2021 Sep 14;23(34):18610-18617. doi: 10.1039/d1cp02619d. Epub 2021 Aug 18.

Interactions between organic molecules and inorganic materials are ubiquitous in many applications and often play significant roles in directing pathways of crystallization. It is frequently debated whether kinetics or thermodynamics plays a more prominent role in the ability of...

Cite
Li R, Elliott WA, Clark RJ, et al. Factors controlling the molecular modification of one-dimensional zeolites. Phys Chem Chem Phys. 2021;23(34):18610-18617doi: 10.1039/d1cp02619d.
Li, R., Elliott, W. A., Clark, R. J., Sutjianto, J. G., Rioux, R. M., Palmer, J. C., & Rimer, J. D. (2021). Factors controlling the molecular modification of one-dimensional zeolites. Physical chemistry chemical physics : PCCP, 23(34), 18610-18617. https://doi.org/10.1039/d1cp02619d
Li, Rui, et al. "Factors controlling the molecular modification of one-dimensional zeolites." Physical chemistry chemical physics : PCCP vol. 23,34 (2021): 18610-18617. doi: https://doi.org/10.1039/d1cp02619d
Li R, Elliott WA, Clark RJ, Sutjianto JG, Rioux RM, Palmer JC, Rimer JD. Factors controlling the molecular modification of one-dimensional zeolites. Phys Chem Chem Phys. 2021 Sep 14;23(34):18610-18617. doi: 10.1039/d1cp02619d. Epub 2021 Aug 18. PMID: 34612398.
Copy Download .nbib Format: NLM
Bendamustine-induced nephrogenic diabetes insipidus - A case report.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Desjardins A, Le-Nguyen V, Turgeon-Mallette L, Vo C, Boudreault JS, Rioux JP, Feng X, Veilleux A.
PMID: 33990157
J Oncol Pharm Pract. 2022 Jan;28(1):205-210. doi: 10.1177/10781552211013878. Epub 2021 May 14.

INTRODUCTION: In patients with relapsed or refractory lymphoma, high-dose chemoimmunotherapy with subsequent autologous hematopoietic cell transplantation (HCT) is a standard of care. Bendamustine, an alkylating agent, is used in the BeEAM (bendamustine, etoposide, cytarabine, melphalan) protocol for conditioning therapy...

Cite
Desjardins A, Le-Nguyen V, Turgeon-Mallette L, et al. Bendamustine-induced nephrogenic diabetes insipidus - A case report. J Oncol Pharm Pract. 2021;28(1):205-210doi: 10.1177/10781552211013878.
Desjardins, A., Le-Nguyen, V., Turgeon-Mallette, L., Vo, C., Boudreault, J. S., Rioux, J. P., Feng, X., & Veilleux, A. (2022). Bendamustine-induced nephrogenic diabetes insipidus - A case report. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 28(1), 205-210. https://doi.org/10.1177/10781552211013878
Desjardins, Audrey, et al. "Bendamustine-induced nephrogenic diabetes insipidus - A case report." Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners vol. 28,1 (2022): 205-210. doi: https://doi.org/10.1177/10781552211013878
Desjardins A, Le-Nguyen V, Turgeon-Mallette L, Vo C, Boudreault JS, Rioux JP, Feng X, Veilleux A. Bendamustine-induced nephrogenic diabetes insipidus - A case report. J Oncol Pharm Pract. 2022 Jan;28(1):205-210. doi: 10.1177/10781552211013878. Epub 2021 May 14. PMID: 33990157.
Copy Download .nbib Format: NLM
Low-molecular-weight-heparin can benefit women with recurrent pregnancy loss and sole protein S deficiency: a historical control cohort study from Taiwan.

Thrombosis journal

Shen MC, Wu WJ, Cheng PJ, Ma GC, Li WC, Liou JD, Chang CS, Lin WH, Chen M.
PMID: 27799851
Thromb J. 2016 Oct 28;14:44. doi: 10.1186/s12959-016-0118-9. eCollection 2016.

BACKGROUND: Heritable thrombophilias are assumed important etiologies for recurrent pregnancy loss. Unlike in the Caucasian populations, protein S and protein C deficiencies, instead of Factor V Lieden and Prothrombin mutations, are relatively common in the Han Chinese population. In...

Cite
Shen MC, Wu WJ, Cheng PJ, et al. Low-molecular-weight-heparin can benefit women with recurrent pregnancy loss and sole protein S deficiency: a historical control cohort study from Taiwan. Thromb J. 2016;14:44doi: 10.1186/s12959-016-0118-9.
Shen, M. C., Wu, W. J., Cheng, P. J., Ma, G. C., Li, W. C., Liou, J. D., Chang, C. S., Lin, W. H., & Chen, M. (2016). Low-molecular-weight-heparin can benefit women with recurrent pregnancy loss and sole protein S deficiency: a historical control cohort study from Taiwan. Thrombosis journal, 1444. https://doi.org/10.1186/s12959-016-0118-9
Shen, Ming-Ching, et al. "Low-molecular-weight-heparin can benefit women with recurrent pregnancy loss and sole protein S deficiency: a historical control cohort study from Taiwan." Thrombosis journal vol. 14 (2016): 44. doi: https://doi.org/10.1186/s12959-016-0118-9
Shen MC, Wu WJ, Cheng PJ, Ma GC, Li WC, Liou JD, Chang CS, Lin WH, Chen M. Low-molecular-weight-heparin can benefit women with recurrent pregnancy loss and sole protein S deficiency: a historical control cohort study from Taiwan. Thromb J. 2016 Oct 28;14:44. doi: 10.1186/s12959-016-0118-9. eCollection 2016. PMID: 27799851; PMCID: PMC5084381.
Copy Download .nbib Format: NLM
The Canadian Society of Nephrology methods in developing and adapting clinical practice guidelines: a review.

Canadian journal of kidney health and disease

Mustafa RA, Levin A, Akbari A, Foster BJ, Zimmerman D, Nesrallah GE, Knoll GA, Rioux JP, Barton J, Ruzicka M, Muirhead N, Moist L, Pannu N, McFarlane P, Klarenbach S, Samuel S, Clark WF, Hemmelgarn BR.
PMID: 25780600
Can J Kidney Health Dis. 2014 May 12;1:5. doi: 10.1186/2054-3581-1-5. eCollection 2014.

INTRODUCTION: The Canadian Society of Nephrology (CSN) was established to promote the highest quality of care for patients with renal diseases and to encourage research related to the kidney and its disorders. The CSN Clinical Practice Guideline (CPG) Committee...

Cite
Mustafa RA, Levin A, Akbari A, et al. The Canadian Society of Nephrology methods in developing and adapting clinical practice guidelines: a review. Can J Kidney Health Dis. 2014;1:5doi: 10.1186/2054-3581-1-5.
Mustafa, R. A., Levin, A., Akbari, A., Foster, B. J., Zimmerman, D., Nesrallah, G. E., Knoll, G. A., Rioux, J. P., Barton, J., Ruzicka, M., Muirhead, N., Moist, L., Pannu, N., McFarlane, P., Klarenbach, S., Samuel, S., Clark, W. F., & Hemmelgarn, B. R. (2014). The Canadian Society of Nephrology methods in developing and adapting clinical practice guidelines: a review. Canadian journal of kidney health and disease, 15. https://doi.org/10.1186/2054-3581-1-5
Mustafa, Reem A, et al. "The Canadian Society of Nephrology methods in developing and adapting clinical practice guidelines: a review." Canadian journal of kidney health and disease vol. 1 (2014): 5. doi: https://doi.org/10.1186/2054-3581-1-5
Mustafa RA, Levin A, Akbari A, Foster BJ, Zimmerman D, Nesrallah GE, Knoll GA, Rioux JP, Barton J, Ruzicka M, Muirhead N, Moist L, Pannu N, McFarlane P, Klarenbach S, Samuel S, Clark WF, Hemmelgarn BR. The Canadian Society of Nephrology methods in developing and adapting clinical practice guidelines: a review. Can J Kidney Health Dis. 2014 May 12;1:5. doi: 10.1186/2054-3581-1-5. eCollection 2014. PMID: 25780600; PMCID: PMC4346300.
Copy Download .nbib Format: NLM
Rapid emergence of meningococci with reduced susceptibility to penicillin in France: the need for vigilance in meningitis treatment.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Struillou L, Chamoux C, Berranger C, Chouillet AM, Riou JY, Raffi F.
PMID: 11864267
Clin Microbiol Infect. 1998 Jan;4(11):661-662. doi: 10.1111/j.1469-0691.1998.tb00351.x.

No abstract available.

Cite
Struillou L, Chamoux C, Berranger C, et al. Rapid emergence of meningococci with reduced susceptibility to penicillin in France: the need for vigilance in meningitis treatment. Clin Microbiol Infect. 1998;4(11):661-662doi: 10.1111/j.1469-0691.1998.tb00351.x.
Struillou, L., Chamoux, C., Berranger, C., Chouillet, A. M., Riou, J. Y., & Raffi, F. (1998). Rapid emergence of meningococci with reduced susceptibility to penicillin in France: the need for vigilance in meningitis treatment. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 4(11), 661-662. https://doi.org/10.1111/j.1469-0691.1998.tb00351.x
Struillou, Laurence, et al. "Rapid emergence of meningococci with reduced susceptibility to penicillin in France: the need for vigilance in meningitis treatment." Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. 4,11 (1998): 661-662. doi: https://doi.org/10.1111/j.1469-0691.1998.tb00351.x
Struillou L, Chamoux C, Berranger C, Chouillet AM, Riou JY, Raffi F. Rapid emergence of meningococci with reduced susceptibility to penicillin in France: the need for vigilance in meningitis treatment. Clin Microbiol Infect. 1998 Jan;4(11):661-662. doi: 10.1111/j.1469-0691.1998.tb00351.x. PMID: 11864267.
Copy Download .nbib Format: NLM
Sustainable Synthesis of .

Antioxidants (Basel, Switzerland)

Rioux B, Peyrot C, Mention MM, Brunissen F, Allais F.
PMID: 32325641
Antioxidants (Basel). 2020 Apr 18;9(4). doi: 10.3390/antiox9040331.

No abstract available.

Cite
Rioux B, Peyrot C, Mention MM, et al. Sustainable Synthesis of . Antioxidants (Basel). 2020;9(4)doi: 10.3390/antiox9040331.
Rioux, B., Peyrot, C., Mention, M. M., Brunissen, F., & Allais, F. (2020). Sustainable Synthesis of . Antioxidants (Basel, Switzerland), 9(4), . https://doi.org/10.3390/antiox9040331
Rioux, Benjamin, et al. "Sustainable Synthesis of ." Antioxidants (Basel, Switzerland) vol. 9,4 (2020). doi: https://doi.org/10.3390/antiox9040331
Rioux B, Peyrot C, Mention MM, Brunissen F, Allais F. Sustainable Synthesis of . Antioxidants (Basel). 2020 Apr 18;9(4). doi: 10.3390/antiox9040331. PMID: 32325641; PMCID: PMC7222392.
Copy Download .nbib Format: NLM
Mapping of fatty acid composition with free-breathing MR spectroscopic imaging and compressed sensing.

NMR in biomedicine

Rioux JA, Hewlett M, Davis C, Bowen CV, Brewer K, Clarke SE, Beyea SD.
PMID: 31898379
NMR Biomed. 2021 May;34(5):e4241. doi: 10.1002/nbm.4241. Epub 2020 Jan 03.

Nonalcoholic fatty liver disease (NAFLD) is a growing health problem, and a major challenge in NAFLD management is identifying which patients are at risk of progression to more serious disease. Simple measurements of liver fat content are not strong...

Cite
Rioux JA, Hewlett M, Davis C, et al. Mapping of fatty acid composition with free-breathing MR spectroscopic imaging and compressed sensing. NMR Biomed. 2020;34(5):e4241doi: 10.1002/nbm.4241.
Rioux, J. A., Hewlett, M., Davis, C., Bowen, C. V., Brewer, K., Clarke, S. E., & Beyea, S. D. (2021). Mapping of fatty acid composition with free-breathing MR spectroscopic imaging and compressed sensing. NMR in biomedicine, 34(5), e4241. https://doi.org/10.1002/nbm.4241
Rioux, James A, et al. "Mapping of fatty acid composition with free-breathing MR spectroscopic imaging and compressed sensing." NMR in biomedicine vol. 34,5 (2021): e4241. doi: https://doi.org/10.1002/nbm.4241
Rioux JA, Hewlett M, Davis C, Bowen CV, Brewer K, Clarke SE, Beyea SD. Mapping of fatty acid composition with free-breathing MR spectroscopic imaging and compressed sensing. NMR Biomed. 2021 May;34(5):e4241. doi: 10.1002/nbm.4241. Epub 2020 Jan 03. PMID: 31898379; PMCID: PMC8244113.
Copy Download .nbib Format: NLM
Effects of chloride ions in acid-catalyzed biomass dehydration reactions in polar aprotic solvents.

Nature communications

Mellmer MA, Sanpitakseree C, Demir B, Ma K, Elliott WA, Bai P, Johnson RL, Walker TW, Shanks BH, Rioux RM, Neurock M, Dumesic JA.
PMID: 30850608
Nat Commun. 2019 Mar 08;10(1):1132. doi: 10.1038/s41467-019-09090-4.

The use of polar aprotic solvents in acid-catalyzed biomass conversion reactions can lead to improved reaction rates and selectivities. We show that further increases in catalyst performance in polar aprotic solvents can be achieved through the addition of inorganic...

Cite
Mellmer MA, Sanpitakseree C, Demir B, et al. Effects of chloride ions in acid-catalyzed biomass dehydration reactions in polar aprotic solvents. Nat Commun. 2019;10(1):1132doi: 10.1038/s41467-019-09090-4.
Mellmer, M. A., Sanpitakseree, C., Demir, B., Ma, K., Elliott, W. A., Bai, P., Johnson, R. L., Walker, T. W., Shanks, B. H., Rioux, R. M., Neurock, M., & Dumesic, J. A. (2019). Effects of chloride ions in acid-catalyzed biomass dehydration reactions in polar aprotic solvents. Nature communications, 10(1), 1132. https://doi.org/10.1038/s41467-019-09090-4
Mellmer, Max A, et al. "Effects of chloride ions in acid-catalyzed biomass dehydration reactions in polar aprotic solvents." Nature communications vol. 10,1 (2019): 1132. doi: https://doi.org/10.1038/s41467-019-09090-4
Mellmer MA, Sanpitakseree C, Demir B, Ma K, Elliott WA, Bai P, Johnson RL, Walker TW, Shanks BH, Rioux RM, Neurock M, Dumesic JA. Effects of chloride ions in acid-catalyzed biomass dehydration reactions in polar aprotic solvents. Nat Commun. 2019 Mar 08;10(1):1132. doi: 10.1038/s41467-019-09090-4. PMID: 30850608; PMCID: PMC6408490.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 146 entries